Sabra Health Care REIT Q3 FFO $0.35, Inline, Sales $178.00M Beat $172.34M Estimate
Portfolio Pulse from Benzinga Newsdesk
Sabra Health Care REIT reported Q3 earnings per share of $0.35, meeting analyst expectations, and sales of $178 million, surpassing estimates by 3.28%. This marks a 6.06% increase in EPS and a 10.13% rise in sales compared to the previous year.
October 31, 2024 | 8:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Sabra Health Care REIT's Q3 earnings per share of $0.35 met expectations, while sales of $178 million exceeded estimates by 3.28%, showing a strong performance with a 10.13% increase in sales year-over-year.
The company's earnings per share met expectations, which is neutral, but the sales beat and year-over-year growth are positive indicators. This suggests a likely positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100